NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer
Jeito Capital co-leads oversubscribed EUR 50 million Series C financing with Brandon Capital CatalYm is developing a new class of anti-cancer immunotherapies, which have already demonstrated initial promising clinical results in advanced-stage solid tumor patients...
Find all our press releases
Jeito Capital becomes significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases
Jeito Capital participates in $120 million financing alongside ARCH Venture Partners and Monograph...
Jeito Capital appoints new team members to support its growth as a European Private Equity fund leader in life sciences
Bastien Renaud is appointed Chief Financial Officer Evaldo Bifulco, Head of Compliance & Risk,...
NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis
Aarhus, Denmark, 11 October 2022 - NMD Pharma A/S, a clinical stage biotech company developing...
Jeito Capital co-leads €75 million Series B financing in SparingVision
Paris, France, September 14, 2022 - Jeito Capital ("Jeito"), a leading independent Private Equity...
Jeito Capital co-leads $76 million Series A financing for CDR-Life its 10th investment since its launch
Paris, France, April 13, 2022 - Jeito Capital ("Jeito"), a leading independent Private Equity firm...
Jeito Capital co-leads EUR 80 million euro Series B financing in European oncology company, Precirix
Paris, France, March 2022, 16th – Jeito Capital (“Jeito”), a leading independent private equity...
Face to face
Meet Jeito
25-28
October
All day long
BIO-Europe 2021
For more than 25 years, BIO-Europe is one of the most influential life sciences trade shows thanks to the synergies it creates in order to bring out medical innovations.
During this event, Sabine Dandigiuan, Managing Partner of Jeito Capital, will participate in the “Talent: finding it, developing it, keeping it” panel.
04-05
October
All day long
HealthTech Innovation Days 2021
Jeito Capital will be Silver Sponsor at HealthTech Innovation Days 2021.
Attend to Rafaèle Tordjman, MD PhD, Keynote on October, 5 at 6.30 PM CET